Stallion India Fluorochemicals FY26 Revenue Up 14.4% to ₹434 Crore; PAT Jumps 35.6%
Stallion India Fluorochemicals reported FY26 Total Revenue of ₹434.12 crore, up 14.40% YoY. PAT increased 35.61% to ₹43.84 crore. The company expects its new R-32 manufacturing facility, commencing October 2026, to drive 30-35% revenue CAGR over three years.
The announcement details strong financial results and significant future growth initiatives, including a major manufacturing facility and ambitious CAGR targets, which are likely to have a substantial impact on investor sentiment and the company's valuation.
The company reported strong financial performance with significant year-on-year growth in revenue, EBITDA, and PAT, exceeding targets despite market volatility. The forward-looking statements regarding the new manufacturing facility and future growth projections are positive.
Stallion India Fluorochemicals Limited (SIFL) has announced its audited financial results for the fourth quarter and full fiscal year 2025-26. The company reported a Total Revenue of ₹434.12 crore for FY26, marking a year-on-year growth of 14.40%. EBITDA increased by 23.34% to ₹61.35 crore, and Profit After Tax (PAT) saw a significant rise of 35.61% to ₹43.84 crore. Earnings Per Share (EPS) grew by 21.92% to ₹5.34.
Despite global volatility in energy and supply chains, SIFL demonstrated resilience by strengthening its sourcing network and inventory planning. The company highlighted its proactive measures in response to geopolitical developments and trade uncertainties.
A key growth driver is the proposed 10,000 MT R-32 manufacturing facility at Bhilwara, Rajasthan, which has received Environmental Clearance. This project, aimed at backward integration and supply chain security, is on track for commencement by October 2026. Management anticipates this facility will support a targeted revenue CAGR of 30–35% over the next three years, with a potential margin improvement of 3–4%. The company also focused on expanding its infrastructure for specialty gases, semiconductor gases, helium, and HFOs during FY26.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.